[HTML][HTML] Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: Multicenter retrospective cohort study
R Lee, SY Cho, DG Lee, H Ahn, H Choi… - The Korean journal of …, 2022 - ncbi.nlm.nih.gov
Methods Between January 2020 and May 2021, data of severely to critically ill COVID-19
patients were extracted from seven hospitals of the Catholic Medical Center through a …
patients were extracted from seven hospitals of the Catholic Medical Center through a …
[HTML][HTML] Risk factors for coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis in critically ill patients: a nationwide, multicenter, retrospective …
SH Kim, JY Hong, S Bae, H Lee… - Journal of Korean …, 2022 - synapse.koreamed.org
Background Coronavirus disease 2019 (COVID-19) is often accompanied by secondary
infections, such as invasive aspergillosis. In this study, risk factors for developing COVID-19 …
infections, such as invasive aspergillosis. In this study, risk factors for developing COVID-19 …
COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study
W Hurt, J Youngs, J Ball, J Edgeworth, P Hopkins… - thorax, 2024 - thorax.bmj.com
Background Invasive pulmonary aspergillosis is a complication of severe COVID-19, with
regional variation in reported incidence and mortality. We describe the incidence, risk factors …
regional variation in reported incidence and mortality. We describe the incidence, risk factors …
[HTML][HTML] COVID-associated pulmonary aspergillosis and its related outcomes: a single-center prospective observational study
A Iqbal, M Ramzan, A Akhtar, A Ahtesham, S Aslam… - Cureus, 2021 - ncbi.nlm.nih.gov
Results Out of the 307 cases of mechanically ventilated COVID-19 pneumonia, 61 had
probable CAPA. The median age was 60 years. Malignancy and cirrhosis were significant …
probable CAPA. The median age was 60 years. Malignancy and cirrhosis were significant …
Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID)
L Desmedt, M Raymond, A Le Thuaut, P Asfar… - Annals of Intensive …, 2024 - Springer
Background Recent studies identified coronavirus disease 2019 (COVID-19) as a risk factor
for invasive pulmonary aspergillosis (IPA) but produced conflicting data on IPA incidence …
for invasive pulmonary aspergillosis (IPA) but produced conflicting data on IPA incidence …
Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis
F Gioia, LN Walti, A Orchanian-Cheff… - The Lancet Respiratory …, 2024 - thelancet.com
Background COVID-19-associated pulmonary aspergillosis (CAPA) has been reported to be
an emerging and potentially fatal complication of severe COVID-19. However, risk factors for …
an emerging and potentially fatal complication of severe COVID-19. However, risk factors for …
[HTML][HTML] COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding
JR Huang, HC Shen, CY Sun, WC Chen… - Journal of the Formosan …, 2022 - Elsevier
Background/Purpose Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) is common in critically ill patients with COVID-19 and is associated with …
aspergillosis (CAPA) is common in critically ill patients with COVID-19 and is associated with …
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis
Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …
Risk of coronavirus disease 2019–associated pulmonary aspergillosis based on corticosteroid duration in intensive care patients
Abstract Background Coronavirus disease 2019 (COVID-19)–associated pulmonary
aspergillosis (CAPA) is a potential complication in critically ill COVID-19 patients …
aspergillosis (CAPA) is a potential complication in critically ill COVID-19 patients …
[HTML][HTML] Incidence and outcomes of patients with COVID-19 associated pulmonary aspergillosis (CAPA) in intensive care units: a systematic review and meta-analysis …
W Chen, C Yin, M Zhong, B Hu, X Gao… - Annals of Palliative …, 2022 - apm.amegroups.org
Background: We aimed to identify studies systematically that describe the incidence and
outcome of COVID-19-related pulmonary aspergillosis (CAPA). Methods: We searched …
outcome of COVID-19-related pulmonary aspergillosis (CAPA). Methods: We searched …
相关搜索
- risk factors pulmonary aspergillosis
- meta analysis pulmonary aspergillosis
- risk factors clinical impact
- clinical impact pulmonary aspergillosis
- outcomes of covid pulmonary aspergillosis
- sars cov pulmonary aspergillosis
- outcomes of patients covid 19
- clinical characteristics outcomes of covid
- homogenous cohort pulmonary aspergillosis
- meta analysis covid 19
- development and mortality pulmonary aspergillosis
- risk factors coronavirus disease
- risk factors meta analysis
- viral shedding pulmonary aspergillosis
- clinical characteristics pulmonary aspergillosis
- incidence and outcome pulmonary aspergillosis